» Articles » PMID: 35483909

DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery

Overview
Specialty Neurology
Date 2022 Apr 28
PMID 35483909
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Differentiation between tumor and radiation necrosis in patients with brain metastases treated with stereotactic radiosurgery is challenging. We hypothesized that MR perfusion and metabolic metrics can differentiate radiation necrosis from progressive tumor in this setting.

Materials And Methods: We retrospectively evaluated MRIs comprising DSC, dynamic contrast-enhanced, and arterial spin-labeling perfusion imaging in subjects with brain metastases previously treated with stereotactic radiosurgery. For each lesion, we obtained the mean normalized and standardized relative CBV and fractional tumor burden, volume transfer constant, and normalized maximum CBF, as well as the maximum standardized uptake value in a subset of subjects who underwent FDG-PET. Relative CBV thresholds of 1 and 1.75 were used to define low and high fractional tumor burden.

Results: Thirty subjects with 37 lesions (20 radiation necrosis, 17 tumor) were included. Compared with radiation necrosis, tumor had increased mean normalized and standardized relative CBV (= .002) and high fractional tumor burden (normalized, = .005; standardized, = .003) and decreased low fractional tumor burden (normalized, = .03; standardized, = .01). The area under the curve showed that relative CBV (normalized = 0.80; standardized = 0.79) and high fractional tumor burden (normalized = 0.77; standardized = 0.78) performed the best to discriminate tumor and radiation necrosis. For tumor prediction, the normalized relative CBV cutoff of ≥1.75 yielded a sensitivity of 76.5% and specificity of 70.0%, while the standardized cutoff of ≥1.75 yielded a sensitivity of 41.2% and specificity of 95.0%. No significance was found with the volume transfer constant, normalized CBF, and standardized uptake value.

Conclusions: Increased relative CBV and high fractional tumor burden (defined by a threshold relative CBV of ≥1.75) best differentiated tumor from radiation necrosis in subjects with brain metastases treated with stereotactic radiosurgery. Performance of normalized and standardized approaches was similar.

Citing Articles

Is pulsed saturation transfer sufficient for differentiating radiation necrosis from tumor progression in brain metastases?.

Chan R, Lam W, Chen H, Murray L, Zhang B, Theriault A Neurooncol Adv. 2024; 6(1):vdae132.

PMID: 39220250 PMC: 11364936. DOI: 10.1093/noajnl/vdae132.


Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.

Anil A, Stokes A, Karis J, Bell L, Eschbacher J, Jennings K AJNR Am J Neuroradiol. 2024; 45(10):1545-1551.

PMID: 38782593 PMC: 11448978. DOI: 10.3174/ajnr.A8357.


How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methods.

Herings S, van den Elshout R, de Wit R, Mannil M, Ravesloot C, Scheenen T Neuroradiology. 2024; 66(8):1279-1289.

PMID: 38714545 PMC: 11246270. DOI: 10.1007/s00234-024-03374-3.


Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration.

Sanvito F, Kaufmann T, Cloughesy T, Wen P, Ellingson B Front Radiol. 2023; 3:1267615.

PMID: 38152383 PMC: 10751345. DOI: 10.3389/fradi.2023.1267615.


Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma.

Iv M, Naya L, Sanan S, Van Buskirk S, Nagpal S, Thomas R Neuroradiol J. 2023; 37(1):107-118.

PMID: 37931176 PMC: 10863570. DOI: 10.1177/19714009231207083.


References
1.
Knitter J, Erly W, Stea B, Lemole G, Germano I, Doshi A . Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation. AJR Am J Roentgenol. 2018; 211(1):168-175. DOI: 10.2214/AJR.17.18890. View

2.
Bedekar D, Jensen T, Schmainda K . Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons. Magn Reson Med. 2010; 64(3):907-13. PMC: 4323176. DOI: 10.1002/mrm.22445. View

3.
Lambert E, Holmes S . Differentiating Radiation-Induced Necrosis from Tumor Progression After Stereotactic Radiosurgery for Brain Metastases, Using Evaluation of Blood Flow with Arterial Spin Labeling (ASL): The Importance of Setting a Baseline. Acta Neurochir Suppl. 2021; 128:113-119. DOI: 10.1007/978-3-030-69217-9_12. View

4.
Nael K, Bauer A, Hormigo A, Lemole M, Germano I, Puig J . Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma. AJR Am J Roentgenol. 2017; 210(1):18-23. DOI: 10.2214/AJR.17.18003. View

5.
Prah M, Al-Gizawiy M, Mueller W, Cochran E, Hoffmann R, Connelly J . Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics. J Neurooncol. 2017; 136(1):13-21. PMC: 5756123. DOI: 10.1007/s11060-017-2617-3. View